Prostate Cancer - Results from #60

PEDAL protocol: a prospective single-arm paired comparison of multiparametric MRI and 18F-DCPFyl PSMA PET/CT to diagnose prostate cancer. September 22, 2022

Differences in Prostate Cancer Transcriptomes by Age at Diagnosis: Are Primary Tumors from Older Men Inherently Different? September 22, 2022

Support-seeking by cancer caregivers living in rural Australia. September 22, 2022

Analysis of BRCA2 Copy Number Loss and Genomic Instability in Circulating Tumor Cells from Patients with Metastatic Castration-resistant Prostate Cancer. September 22, 2022

Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses. September 22, 2022

Transcriptomes of prostate cancer with TMPRSS2:ERG and other ETS fusions. September 22, 2022

Surgical Results and Complications for Open, Laparoscopic, and Robot-assisted Radical Prostatectomy: A Reverse Systematic Review. September 21, 2022

Oncological and functional outcomes of men undergoing primary whole gland cryoablation of the prostate: A 20-year experience. September 21, 2022

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial. September 21, 2022

Clinical application of a sub-fractionation workflow for intrafraction re-planning during prostate radiotherapy treatment on a 1.5 Tesla MR-Linac: a practical method to mitigate intrafraction motion. September 21, 2022

Impact of dynamic contrast-enhanced MRI in 1.5 T versus 3 T MRI for clinically significant prostate cancer detection. September 21, 2022

Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate Cancer. September 21, 2022

Trial Participation is Not Associated with Better Biochemical Recurrence-free Survival in a Large Cohort of External Beam Radiotherapy-Treated Intermediate- and High-Risk Prostate Cancer Patients. September 20, 2022

Failure patterns by PSMA PET for recurrent prostate cancer after prostatectomy and salvage radiation. September 20, 2022

Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity. September 20, 2022

B7-H3 as a Therapeutic Target in Advanced Prostate Cancer. September 20, 2022

Subtype and site specific-induced metabolic vulnerabilities in prostate cancer. September 20, 2022

Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer. September 20, 2022

Whole-exome Sequencing of Nigerian Prostate Tumors from the Prostate Cancer Transatlantic Consortium (CaPTC) Reveals DNA Repair Genes Associated with African Ancestry September 19, 2022

Prostate Tumor Biology May Be Influenced by Genetic Ancestry September 19, 2022

Page 4 of 1252

email news signup